|Articles|June 20, 2018
TrialScope Selected to Support Clinical Trial Disclosure and Transparency
Advertisement
TrialScope announced that it has been selected by GlaxoSmithKline plc to facilitate clinical trial disclosure and transparency which amounts to disclosing more than 1,200 records per year from studies conducted in over 90 countries around the globe.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
4
Using AI and Tokenized Data to Match Patients to Protocols
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
